Key result
Mebudipine and dibudipine reversibly reduced the peak amplitude of action potential and markedly decreased the duration of Ca2+ spikes in Helix aspersa neurons compared to nifedipine.
Mebudipine and dibudipine demonstrate potent L-type Ca2+ channel blocking activity in a snail neuronal model, with mebudipine showing greater potency.
Answers are grounded in this paper and cite their sources.
No direct clinical implications; leaves open mebudipine's potency in mammalian cardiovascular models.
Mebudipine and dibudipine are two new dihydropyridine (DHP) Ca2+ channel blockers that have been synthesized by Mahmoudian et al. (1997). In previous studies, they showed considerable relaxant effect on vascular and ileal smooth muscles. These two compounds also reduced the contraction force of rat left atrium (20, 22). In the present study, we attempted to compare the inhibitory actions of these new DHPs and nifedipine on the high threshold Ca2+ spikes of F1 neuronal soma membrane in the subesophageal ganglia of Helix aspersa, using current-clamp method. At a concentration of 1 microM, two new DHP compounds (mebudipine and dibudipine) were tested for their L-type Ca2+ channel blocker activity. Both compounds reversibly reduced the peak amplitude of action potential and after hyperpolarization potential and markedly decreased the duration of Ca2+ spikes. The most potent of these DHPs was mebudipine. Neither the two new DHPs nor nifedipine changed the resting membrane potential in a statistically significant way.
No takes yet. Share an insight, caveat, or question.
Faizi et al. (2003) studied this question. Mebudipine and dibudipine vs. Nifedipine was evaluated on High threshold Ca2+ spikes of F1 neuronal soma membrane. Mebudipine and dibudipine reversibly reduced the peak amplitude of action potential and markedly decreased the duration of Ca2+ spikes in Helix aspersa neurons compared to nifedipine.
Synapse has enriched 10 related papers. Consider them for comparative context: